Valuation: Ha Tay Pharmaceutical

Market Cap 4,900B 188M 164M 155M 141M 264M 18.07B 265M 1.86B 717M 9.19B 707M 692M 29.56B P/E 2024
109x
P/E 2025 109x
Enterprise Value 4,999B 192M 167M 158M 144M 269M 18.43B 270M 1.89B 731M 9.37B 722M 706M 30.15B EV / Sales 2024
3.89x
EV / Sales 2025 2.68x
Free-Float
25%
Yield 2024 *
-
Yield 2025 -
1 day+0.19%
1 week-1.64%
Current month-4.42%
1 month-3.57%
3 months-18.40%
6 months-21.93%
Current year-22.71%
1 week 52,500
Extreme 52500
58,000
1 month 52,500
Extreme 52500
59,900
Current year 52,500
Extreme 52500
75,800
1 year 52,500
Extreme 52500
86,800
3 years 17,090.91
Extreme 17090.90909
100,818.18
5 years 11,980.52
Extreme 11980.519478
100,818.18
10 years 4,801.26
Extreme 4801.259345
100,818.18
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2016
Corporate Officer/Principal - 01/03/2016
Corporate Officer/Principal 49 04/02/2015
Director TitleAgeSince
Chairman 75 01/01/2016
Director/Board Member 53 -
Director/Board Member 62 01/06/2013
Change 5-day change 1-year change 3-year change Capi.($)
+0.19%-1.64%-30.96%+174.24% 188M
+0.04%+3.34%+51.12%+101.82% 1,028B
-0.09%+1.66%+55.02%+66.18% 651B
-0.02%+2.66%+18.91%+71.47% 466B
-1.22%+3.66%+36.44%+38.32% 346B
-0.79%+2.73%+19.03%+25.08% 266B
+0.58%+6.76%+11.13%+16.52% 259B
+1.55%+2.20%+39.81%+46.55% 208B
+0.79%+1.84%-28.27%-56.71% 191B
-0.52%+4.45%+32.12%+98.51% 186B
Average +0.20%+2.75%+20.44%+58.20% 360.19B
Weighted average by Cap. +0.23%+3.09%+35.15%+61.77%

Financials

2024 2025
Net sales 2,086B 80.17M 69.91M 66.01M 59.94M 112M 7.69B 113M 791M 305M 3.91B 301M 294M 12.58B 2,402B 92.3M 80.49M 76M 69.01M 129M 8.86B 130M 910M 351M 4.5B 347M 339M 14.49B
Net income 71.77B 2.76M 2.4M 2.27M 2.06M 3.86M 265M 3.88M 27.2M 10.5M 135M 10.36M 10.13M 433M 53.66B 2.06M 1.8M 1.7M 1.54M 2.89M 198M 2.9M 20.34M 7.85M 101M 7.75M 7.57M 324M
Net Debt 290B 11.14M 9.71M 9.17M 8.33M 15.61M 1.07B 15.67M 110M 42.4M 543M 41.85M 40.92M 1.75B 98.73B 3.79M 3.31M 3.12M 2.84M 5.31M 364M 5.34M 37.42M 14.44M 185M 14.25M 13.93M 595M
Logo Ha Tay Pharmaceutical
Hatay Pharmaceutical Joint Stock Company (Hataphar) is a Vietnam-based pharmaceutical company. It is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The Company also manufactures and trades cosmetic products, supplemental food, general chemicals and specialized chemicals for laboratory tests. Other activities include supermarket operations, office and apartment leasing, real estate brokerage services, as well as the provision of vocational training services. The Company announced that it has completed the acquisition of 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company by the end of the third quarter of 2013.
Employees
586
Date Price Change Volume
18/09/26 ₫54,100.00 +0.19% 5,000
17/09/26 ₫54,000.00 0.00% 2,500
16/09/26 ₫54,000.00 -1.82% 13,011
15/09/26 ₫55,000.00 -0.18% 12,545
14/09/26 ₫55,100.00 +0.18% 1,820
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!